ImmuCell Corporation (ICCC) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

ImmuCell Corporation (ICCC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $89.9M, listed on NASDAQ, employing roughly 73 people, carrying a beta of 0.57 to the broader market. ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U. Led by F. Olivier Te Boekhorst, public since 1987-05-05.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ICCC as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →